絞り込み

16551

広告

「"Couch FJ"[Author]」の検索結果

402件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Cancer susceptibility gene mutations in type I and II endometrial cancer.

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.

Genetic susceptibility to radiation-induced breast cancer after Hodgkin Lymphoma.

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels.

Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

A contemporary review of male breast cancer: current evidence and unanswered questions.

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.

Identification of nine new susceptibility loci for endometrial cancer.

A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk.

Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status.

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.

Current Approaches to Cancer Genetic Counseling Services for Spanish-Speaking Patients.

BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります